Page 2 - Nasdaq Aura News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Monashee Investment Management LLC purchased a new stake in Aura Biosciences, Inc. (NASDAQ:AURA – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 131,640 shares of the company’s stock, valued at approximately $1,382,000. Monashee Investment Management LLC owned approximately […]

Aura Biosciences, Inc. (NASDAQ:AURA – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 1,560,000 shares, an increase of 24.8% from the March 15th total of 1,250,000 shares. Approximately 6.0% of the company’s stock are sold short. Based […]

Aura Biosciences (NASDAQ:AURA – Get Rating) and Scholar Rock (NASDAQ:SRRK – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation. Profitability This table compares Aura Biosciences and Scholar Rock’s […]

Aura Biosciences (NASDAQ:AURA – Get Rating) is one of 283 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its rivals? We will compare Aura Biosciences to similar companies based on the strength of its dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership. Analyst Recommendations This is […]

Aura Biosciences (NASDAQ:AURA – Get Rating) is one of 282 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare Aura Biosciences to related businesses based on the strength of its risk, analyst recommendations, dividends, earnings, valuation, profitability and institutional ownership. Analyst Ratings This is […]